JP Patent

JP7110446B2 — ２，４，６－トリフルオロ－ｎ－［６－（１－メチル－ピペリジン－４－カルボニル）－ピリジン－２－イル］－ベンズアミドの組成物

Assigned to コルーシッド ファーマシューティカルズ， インコーポレイテッド · Expires 2022-08-01 · 4y expired

What this patent protects

Patent listed against lasmiditan-succinate.

Drugs covered by this patent

Patent Metadata

Patent number
JP7110446B2
Jurisdiction
JP
Classification
—
Expires
2022-08-01
Drug substance claim
No
Drug product claim
No
Assignee
コルーシッド ファーマシューティカルズ， インコーポレイテッド
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.